Home
>
US Stocks
>
CRISPR Therapeutics AG
CRISPR Therapeutics AG
CRSP

CRISPR Therapeutics AG (CRSP)

$64.470.89%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$65.45
Today Low/High$64.02 / $68.72
52 Week Low/High$63.86 / $200.85
P/E ratio11.82
Market Cap$5.19B

Company Details

CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc.CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom.
OrganisationCRISPR Therapeutics AG
HeadquatersZug, Zug, Switzerland
Employees304
IndustryHealth Technology
CEOSamarth Kulkarni

Discover more

Frequently Asked Questions

What is CRISPR Therapeutics AG (CRSP) share price today?

Can Indians buy CRISPR Therapeutics AG (CRSP) shares?

How can I buy CRISPR Therapeutics AG (CRSP) shares from India?

Can Fractional shares of CRISPR Therapeutics AG (CRSP) be purchased?

What are the documents required to start investing in CRISPR Therapeutics AG (CRSP) stocks?